Keyphrases
Induced Apoptosis
100%
Phospholipase A2 Activating Protein
100%
Cisplatin
100%
HeLa Cells
100%
Cisplatin-induced
100%
Clusterin
45%
Small Interfering RNA (siRNA)
36%
Arachidonic Acid
27%
DNA Fragmentation
27%
Cytochrome c (Cyt c)
27%
Protein Induction
27%
Interleukin-32 (IL-32)
27%
C-Jun
18%
Mitochondrial Damage
18%
HeLa
18%
FasL
18%
Protein-DNA Complex
9%
Phospholipase A2 (PLA2)
9%
Inflammatory Response
9%
Overexpressing
9%
Interleukin-4 (IL-4)
9%
Signaling Molecules
9%
Mitochondria
9%
Enzyme Activity
9%
Proteomic Analysis
9%
Pro-apoptotic
9%
Anti-apoptotic Proteins
9%
Cell Viability
9%
Protein Production
9%
Caspase-3 Activity
9%
Tet-on
9%
Caspase-8
9%
Eicosanoid Metabolism
9%
Cancer Resistance
9%
Apoptotic Effect
9%
Caspase-9 Activity
9%
Cervical Carcinoma Cells
9%
Acid Damage
9%
Phospholipase A2 Enzyme
9%
Immunology and Microbiology
DNA Fragmentation
100%
Protein Induction
100%
Inflammation Response
33%
Upregulation
33%
Downregulation
33%
Enzyme Activity
33%
Mitochondrion
33%
Caspase
33%
Drug Resistance
33%
Carcinoma Cell
33%
Cell Viability
33%
Biochemistry, Genetics and Molecular Biology
Phospholipase A2
100%
Cisplatin
100%
Clusterin
33%
Small Interfering RNA
26%
DNA Fragmentation
20%
Protein Induction
20%
Arachidonic Acid
20%
Cytochrome C
20%
Eicosanoid
6%
Proteomics
6%
Mitochondrion
6%
Upregulation
6%
Downregulation
6%
Enzyme Activity
6%
Cell Viability
6%
Caspase 3
6%
Drug Resistance
6%
Caspase-9
6%
Caspase 8
6%
Neuroscience
Phospholipase A2
100%
Cisplatin
100%
Clusterin
33%
Small Interfering RNA
26%
Arachidonic Acid
20%
DNA Fragmentation
20%
Cytochrome C
20%
Protein Induction
20%
Eicosanoid
6%
Mitochondrion
6%
Proteomics
6%
Caspase 3
6%
Enzyme Activity
6%
Cell Viability
6%
Caspase-9
6%
Drug Resistance
6%
Caspase 8
6%
Pharmacology, Toxicology and Pharmaceutical Science
Phospholipase A2
100%
Cisplatin
100%
Clusterin
33%
Small Interfering RNA
26%
Arachidonic Acid
20%
Cytochrome C
20%
Cytoprotective Agent
13%
Malignant Neoplasm
6%
Deoxyribonucleoprotein
6%
Inflammation
6%
Antiinfective Agent
6%
Caspase 3
6%
Drug Resistance
6%
Cell Viability
6%
Icosanoid
6%
Caspase 8
6%
Caspase 9
6%
Uterine Cervix Carcinoma
6%